Antiangiogenic Therapies for Mesothelioma
- 1 December 2005
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 19 (6) , 1137-1145
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Effect of inhibition of multiple steps of angiogenesis in syngeneic murine pleural mesotheliomaThe Annals of Thoracic Surgery, 2004
- Moving beyond chemotherapy: novel cytostatic agents for malignant mesotheliomaLung Cancer, 2004
- Clinico-pathological and biological prognostic factors in pleural malignant mesotheliomaLung Cancer, 2004
- Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over timeJournal of Magnetic Resonance Imaging, 2004
- Preclinical evaluation of the nonsteroidal anti‐inflammatory agent celecoxib on malignant mesothelioma chemopreventionInternational Journal of Cancer, 2004
- O-26 Thalidomide alone or in combination with cisplatin/Gemcitabine in malignant pleural mesothelioma (MM); Interim results from two parallel non randomized phase II studiesLung Cancer, 2003
- Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF‐C autocrine loopsInternational Journal of Cancer, 2003
- SV40 and human tumours: myth, association or causality?Nature Reviews Cancer, 2002
- Methionine Aminopeptidase-2 Regulates Human Mesothelioma Cell SurvivalThe American Journal of Pathology, 2001
- EXPRESSION OF PLATELET-DERIVED GROWTH FACTOR (PDGF) AND PDGF RECEPTORS IN HUMAN MALIGNANT MESOTHELIOMAIN VITRO ANDIN VIVOThe Journal of Pathology, 1996